Update on pharmacogenetics in cancer chemotherapy

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
F Innocenti, M J Ratain

Abstract

This review describes how genetic differences among patients may change the therapeutic outcome in cancer chemotherapy. Severe toxicity in genetically predisposed patients is predominantly associated with mutations in drug metabolism enzyme genes, and an update on genetic intolerance to 6-mercaptopurine, 5-fluorouracil, and irinotecan is provided. Moreover, recent findings pointed out that the methylenetetrahydrofolate reductase (MTHFR) C677T mutation might change patient susceptibility to the toxic effects of the cyclophosphamide, methotrexate, 5-fluorouracil (CMF) regimen and raltitrexed. Finally, it is emerging that not only toxicity, but also response to chemotherapy could be influenced by pharmacogenetic determinants, and the clinical relevance of polymorphisms in thymidylate synthase (TS) and glutathione-S-transferase (GST) genes is discussed.

References

May 11, 1991·Nucleic Acids Research·K JolliffL F Johnson
Jan 1, 1990·Cancer Chemotherapy and Pharmacology·J RobertC Granger
Apr 14, 1989·Science·B VogelsteinR White
Nov 2, 1995·The New England Journal of Medicine·P J BosmaR P Oude Elferink
Jan 1, 1995·Genetic Epidemiology·J P VuchetichR A Price
Mar 2, 1996·Lancet·H SatoO Koiwai
Feb 21, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A B Van KuilenburgA H van Gennip
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·E BeutlerA Demina
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·P J Bagley, J Selhub
Dec 1, 1998·British Journal of Pharmacology·C Spire-Vayron de la MoureyreF Broly
Dec 23, 1998·Atherosclerosis·L BrattströmP M Ueland
Dec 2, 1999·Journal of the National Cancer Institute·M V RellingW E Evans
May 10, 2000·Pharmacogenetics·E S Collie-DuguidH L McLeod
Sep 6, 2000·Pharmacology·J D Hayes, R C Strange
Apr 3, 2001·Trends in Pharmacological Sciences·P M UelandS E Vollset
Jul 27, 2001·Briefings in Bioinformatics·C V Jongeneel
Sep 6, 2001·Mutation Research·R C StrangeA A Fryer
Nov 1, 2001·International Journal of Colorectal Disease·A M YousefS H Berger
Mar 27, 2002·The Pharmacogenomics Journal·S T PullarkatH J Lenz
May 7, 2002·The Pharmacogenomics Journal·L IyerM J Ratain
Jul 13, 2002·Expert Review of Anticancer Therapy·A K Daly, A G Hall

❮ Previous
Next ❯

Citations

Jul 10, 2003·Gastroenterology·Raymond C Givens, Paul B Watkins
Mar 6, 2003·Biochimica Et Biophysica Acta·James W Watters, Howard L McLeod
Jan 20, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L Iyer, M J Ratain
Jul 17, 2003·ANZ Journal of Surgery·Heather JefferiesJohn C Hall
Dec 19, 2002·Journal of the National Cancer Institute·Sharyn D BakerAlex Sparreboom
Sep 16, 2005·Anti-cancer Drugs·Myrna CandelariaAlfonso Dueñas-Gonzalez
May 13, 2009·American Journal of Therapeutics·Joseph Prandota
Oct 16, 2004·Journal of Epidemiology and Community Health·Jane L HallidayCraig A Olsson
May 16, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Mikael Oscarson
Mar 3, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·Raffaele Di FranciaPamela Pinzani
Sep 12, 2002·Pharmacogenomics·Marina E Chicurel, Dennise D Dalma-Weiszhausz
Nov 5, 2003·Pharmacogenomics·Christopher HullSancy Leachman
Mar 6, 2004·Expert Review of Molecular Diagnostics·Jeffrey S RossLajos Pusztai
Nov 22, 2007·Expert Opinion on Drug Metabolism & Toxicology·Michael Michael, Margaret M Doherty
Oct 13, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Mikkel RosendahlMichael Andersson
Mar 11, 2004·Mayo Clinic Proceedings·Matthew P GoetzRichard M Weinshilboum
Jul 13, 2007·La Revue de médecine interne·F CeppaP Burnat
Feb 20, 2007·Clinica Chimica Acta; International Journal of Clinical Chemistry·Evgeny N Imyanitov, Vladimir M Moiseyenko
Dec 5, 2006·Biochimica Et Biophysica Acta·Jean AbrahamCarlos Caldas
Apr 14, 2005·Journal of Cellular Physiology·Antonio RussoViviana Bazan
Feb 14, 2006·Seminars in Oncology·Justin FloydMichael C Perry
Dec 20, 2005·Toxicology in Vitro : an International Journal Published in Association with BIBRA·N HariparsadP B Desai
Dec 6, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ron H J Mathijssen, Ron H N van Schaik
Oct 22, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Michael C G Stevens
Apr 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tiffany A TrainaClifford Hudis
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John D ChesterMatthew T Seymour
Oct 7, 2003·Oncogene·Apurva A DesaiMark J Ratain
Jul 13, 2019·Clinical Pharmacology and Therapeutics·Mark J Ratain
Feb 15, 2005·The Oncologist·Wooin LeeMace L Rothenberg
Mar 1, 2005·Personalized Medicine·Jeantine Lunshof
Jan 26, 2005·Journal of Health Services Research & Policy·David MelzerRon Zimmern
Aug 1, 2007·Personalized Medicine·Richard C TurkingtonMartin M Eatock
Jun 29, 2004·Advances in Anatomic Pathology·Jeffrey S RossGabriel N Hortobagyi
Nov 19, 2019·Journal of Gastrointestinal Cancer·Majid EslamiBahman Yousefi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.